首页> 外文会议>2nd International Conference on Trendz in Information Sciences Computing >Computer aided drug design strategies for the development of novel beta lactam analogs targeting penicillin binding proteins
【24h】

Computer aided drug design strategies for the development of novel beta lactam analogs targeting penicillin binding proteins

机译:开发针对青霉素结合蛋白的新型β-内酰胺类似物的计算机辅助药物设计策略

获取原文

摘要

Computers and computational methods are indispensable tools in modern drug discovery pipeline. Early lead identification and lead optimization are the present day goals of drug discovery. Antibiotics like penicillin and cephalosporin containing beta lactam ring system are the dominant class of agents currently used for the chemotherapy of bacterial infections. In this present study we have used an approach combing molecular docking and QSAR analyses on a series of compounds called Imidazetines, a novel beta lactam analog known to possess antibacterial activity. X-ray crystallographic studies reveal that beta lactam compounds have affinity for Penicillin Binding Proteins (PBP) and hence known 3D structure of PBP (pdb code: 1CEF) was used as macromolecular target. Molecular modeling studies were performed on Silicon Graphics work stations using Insight II. The novel ligands were docked in to the binding pocket and the results of the docking studies revealed that these novel ligands are able to occupy the same binding pocket with better interactions. The stability of the complex are maintained by several hydrogen bonding interactions. The key amino acid residues involved in ligand binding were found to be conserved among other homologous of PBP. QSAR analyses were performed on these compounds and ADME/T properties were predicted based on the first generation Lipinski's Rule of Five. The results obtained from our study could further the design of new molecules with promising activity in the future.
机译:计算机和计算方法是现代药物开发流程中必不可少的工具。早期线索识别和线索优化是药物发现的当今目标。含青霉素和头孢菌素的抗生素(含β-内酰胺环系统)是目前用于细菌感染化学疗法的主要药物。在本研究中,我们采用了将分子对接和QSAR分析相结合的方法,对一系列称为亚胺西汀的化合物进行了研究,该化合物是一种新型的具有抗菌活性的β-内酰胺类似物。 X射线晶体学研究表明,β-内酰胺化合物对青霉素结合蛋白(PBP)具有亲和力,因此已知的PBP 3D结构(pdb代码:1CEF)被用作大分子靶标。使用Insight II在Silicon Graphics工作站上进行了分子建模研究。将新的配体对接到结合袋中,对接研究的结果表明,这些新的配体能够以更好的相互作用占据相同的结合袋。配合物的稳定性通过几种氢键相互作用来维持。发现与配体结合有关的关键氨基酸残基在PBP的其他同源物中是保守的。对这些化合物进行了QSAR分析,并根据第一代Lipinski的5规则预测了ADME / T性质。从我们的研究中获得的结果可能会进一步设计具有未来活性的新分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号